文献速递肝病消化道出血

肝硬化患者的出血与血栓并发症:最新进展评述

Bleeding and Thrombotic Complications in Patients With Cirrhosis: A State-of-the-Art Appraisal.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-04-28

本文评述肝硬化凝血病的认识演变,指出其实际呈相对高凝状态,出血主要源于门静脉高压而非止血通路;INR不能有效评估凝血状态,可能误导新鲜冰冻血浆等干预而加重门脉压力驱动性出血。文章讨论操作相关出血高风险定义差异并提出基于局部止血措施可及性的新操作定义,强调静脉血栓常见需权衡抗凝风险获益,决策应结合非门脉高压相关出血史、跌倒风险、感染和肾功能等,遗传性易栓症在肝硬化中或不能抵消肝病固有易栓倾向但需进一步考虑。

要点

  • 肝硬化凝血病实际呈相对高凝状态,出血倾向主要由门静脉高压驱动,与止血通路关系不大。
  • INR不能有效反映肝硬化患者的凝血状态,以其指导新鲜冰冻血浆可能加重门脉高压和压力驱动性出血。
  • 操作相关出血高风险定义存在显著差异,作者提出基于局部止血措施可及性的新操作定义,但尚需进一步研究。

核心结论

  • 肝硬化凝血病实际呈相对高凝状态而非出血倾向,出血主要由门静脉高压驱动,INR无有效评估价值且可能误导干预。
  • 静脉血栓常见,抗凝决策需综合评估非门脉高压相关出血史和跌倒风险,后者在易发生肝性脑病患者中可致头部外伤。
  • 操作相关出血高风险定义存在显著差异,作者提出的基于局部止血措施可及性的新操作定义尚需进一步研究。

研究设计与样本

  • 本文为最新进展评述,回顾过去25年对肝病凝血病认识演变并汇总相关证据与观点。

主要发现

  • 肝硬化凝血病相对高凝,临床出血倾向主要由门静脉高压驱动,与止血通路关系不大。
  • INR在此情境下不提供有意义的测量,可能导致新鲜冰冻血浆等干预而加重门脉压力及压力驱动性出血。
  • 高风险操作定义存在显著差异,作者提出基于局部止血措施可及性的新操作定义,但尚需进一步研究。
  • 静脉血栓常见,抗凝决策需综合评估非门脉高压相关出血史和跌倒风险,跌倒风险在易发生肝性脑病患者中可致头部外伤,或最好用衰弱评估但尚待充分研究。
  • 感染和肾功能不全等叠加复杂情况应纳入考虑,肝硬化中的遗传性易栓症或不能抵消肝病固有易栓倾向但需进一步考虑。

关键数值与推荐

  • INR在此情境下不提供有意义的测量,可能导致新鲜冰冻血浆等干预而加重门脉压力及压力驱动性出血。
  • 作者提出基于局部止血措施可及性的新操作定义,但尚需进一步研究。
  • 抗凝决策需综合评估非门脉高压相关出血史和跌倒风险,跌倒风险或最好用衰弱评估但尚待充分研究。
  • 遗传性易栓症在肝硬化中或不能抵消肝病固有易栓倾向,但需进一步考虑。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者提出的基于局部止血措施可及性的新操作定义尚需进一步研究。
  • 跌倒风险或最好用衰弱评估但尚待充分研究。
  • 肝硬化中的遗传性易栓症或不能抵消肝病固有易栓倾向但需进一步考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Much has evolved over the past 25 years regarding our understanding of the coagulopathy of liver disease. Paradoxically, this form of coagulopathy is relatively hypercoagulability despite the common clinical impression of a hemorrhagic tendency. The latter is largely driven by portal-mesenteric venous pressure (ie, portal hypertension) and has little to do with hemostatic pathways. It cannot be emphasized enough that the INR does not offer a meaningful measure in this situation and may lead to interventions such as fresh frozen plasma that can actually worsen portal pressure and hence pressure-driven bleeding. With regard to procedure-related bleeding, we point out substantial differences in the definition of high-risk procedures and propose a new operational definition dependent on the applicability of local hemostatic measures, although this requires further investigation. The common occurrence of venous thrombosis in these patients requires careful consideration of hemostatic pathways and overall risk and benefit of intervention. The decision regarding anticoagulation therapy needs to be driven not only by a global assessment including history of non-portal hypertensive-related bleeding, but also by fall risk which can result in head trauma in patients prone to encephalopathy. This is probably best estimated by frailty but has yet to be adequately investigated. In the background of these concerns, several superimposed and complex conditions including infections and renal dysfunction should be taken into account. Inherited forms of thrombophilia in the setting of cirrhosis perhaps do not outweigh the thrombophilia inherent to liver disease but warrant further consideration.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Rautou PE, Caldwell SH, Villa E, et al. Bleeding and Thrombotic Complications in Patients With Cirrhosis: A State-of-the-Art Appraisal. Clin Gastroenterol Hepatol. 2023. PMID: 37121529. doi:10.1016/j.cgh.2023.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。